Bulk drug dependency tracker

The 41 bulk drugs identified under the PLI scheme, by target segment, plus inputs tracked outside that list. Every value carries a last-updated date and a source, and anything not yet traced to a primary source reads “Not known” rather than being estimated — click a molecule for the full detail view.

Data last reviewed 9 Oct 2026Download the full dataset as CSV ↓

The 41 by target segment

Named applicant means the Dept. of Pharmaceuticals has published a company against that product. The Department reports 48 projects covering 33 of the 41 in aggregate without naming them all, so 10 is the number that can be sourced per-product today, not the number of approved projects.

Segment I — fermentation-based KSMs/DIs: 4products
3 with a named applicant
Segment II — fermentation-based niche KSMs/DIs/APIs: 10products
5 with a named applicant
Segment III — key chemical synthesis KSMs/DIs: 4products
2 with a named applicant
Segment IV — other chemical synthesis KSMs/DIs/APIs: 23products
0 with a named applicant

PLI target segment

End-use category

PLI critical list

43 of 43 molecules

PLI minimum annual capacity is the capacity an applicant had to commit to in order to apply for that product — an eligibility threshold set by the Department of Pharmaceuticals, not a measurement. It is not India’s installed capacity, not its consumption, and not the size of any plant anyone has built. It is shown only for the products put into an unsubscribed-product application round; every other row reads “Not applicable”, because no minimum was ever set for those. Source: DoP notice 14 May 2025, No. 31026/16/2020-Policy, and the notice of 26 November 2025 for Meropenem and Ritonavir — attached per row, with the rest of each row’s sources, on its molecule page.


7-ACA	Segment I	—	Not known	Yes	Karnataka Antibiotics and Pharmaceuticals	Not applicable	Antibiotic intermediate
Clavulanic Acid	Segment I	—	Not known	Yes	Kinvan	Not applicable	Beta-lactamase inhibitor
Erythromycin Thiocyanate	Segment I	—	Not known	Yes	Not known	800	Antibiotic
Penicillin G	Segment I	29411010	Not known	Yes	Aurobindo Pharma (via Lyfius Pharma)	Not applicable	Antibiotic
Betamethasone	Segment II	—	Not known	Yes	Natural Biogenex	Not applicable	Corticosteroid
Clindamycin Base	Segment II	—	Not known	Yes	Not known	60	Antibiotic
Dexamethasone	Segment II	—	Not known	Yes	Natural Biogenex	Not applicable	Corticosteroid
Gentamycin	Segment II	—	Not known	Yes	Not known	40	Antibiotic
Neomycin	Segment II	—	Not known	Yes	Not known	80	Antibiotic
Prednisolone	Segment II	—	Not known	Yes	Natural Biogenex	Not applicable	Corticosteroid
Rifampicin	Segment II	—	Not known	Yes	Macleods	Not applicable	Antibiotic
Streptomycin	Segment II	—	Not known	Yes	Not known	50	Antibiotic
Tetracycline	Segment II	—	Not known	Yes	Not known	200	Antibiotic
Vitamin B1	Segment II	—	Not known	Yes	Sudarshan Pharma Industries	Not applicable	Vitamin
1,1 Cyclohexane Diacetic Acid	Segment III	—	Not known	Yes	Emmennar Pharma	1,500	Chemical intermediate
2-Methyl-5-Nitro-Imidazole	Segment III	—	Not known	Yes	Not known	800	Chemical intermediate
Dicyandiamide	Segment III	—	Not known	Yes	Not known	8,000	Chemical intermediate
Para amino phenol	Segment III	—	Not known	Yes	Meghmani	Not applicable	Chemical intermediate
Acyclovir	Segment IV	—	Not known	Yes	Not known	Not applicable	Antiviral
Artesunate	Segment IV	—	Not known	Yes	Not known	Not applicable	Antimalarial
Aspirin	Segment IV	—	Not known	Yes	Not known	Not applicable	Analgesic / NSAID
Atorvastatin	Segment IV	—	Not known	Yes	Not known	Not applicable	Cardiovascular
Carbamazepine	Segment IV	—	Not known	Yes	Not known	Not applicable	Anticonvulsant
Carbidopa	Segment IV	—	Not known	Yes	Not known	Not applicable	Antiparkinson's
Ciprofloxacin	Segment IV	—	Not known	Yes	Not known	150	Antibiotic
Diclofenac Sodium	Segment IV	—	Not known	Yes	Not known	175	Analgesic / NSAID
Levetiracetam	Segment IV	—	Not known	Yes	Not known	Not applicable	Anticonvulsant
Levodopa	Segment IV	—	Not known	Yes	Not known	Not applicable	Antiparkinson's
Levofloxacin	Segment IV	—	Not known	Yes	Not known	Not applicable	Antibiotic
Lopinavir	Segment IV	—	Not known	Yes	Not known	Not applicable	Antiviral
Losartan	Segment IV	—	Not known	Yes	Not known	Not applicable	Antihypertensive
Meropenem	Segment IV	—	Not known	Yes	Not known	4	Antibiotic
Norfloxacin	Segment IV	—	Not known	Yes	Not known	Not applicable	Antibiotic
Ofloxacin	Segment IV	—	Not known	Yes	Not known	Not applicable	Antibiotic
Olmesartan	Segment IV	—	Not known	Yes	Not known	Not applicable	Antihypertensive
Oxcarbazepine	Segment IV	—	Not known	Yes	Not known	Not applicable	Anticonvulsant
Ritonavir	Segment IV	—	Not known	Yes	Not known	5	Antiviral
Sulfadiazine	Segment IV	—	Not known	Yes	Not known	Not applicable	Antibiotic
Telmisartan	Segment IV	—	Not known	Yes	Not known	Not applicable	Antihypertensive
Valsartan	Segment IV	—	Not known	Yes	Not known	Not applicable	Antihypertensive
Vitamin B6	Segment IV	—	Not known	Yes	Not known	Not applicable	Vitamin
6-APA	Not on PLI 41	29411050	Not known	No	No	Not applicable	Antibiotic intermediate
Amoxicillin Trihydrate	Not on PLI 41	29411030	Not known	No	No	Not applicable	Antibiotic

7-ACA
Segment
Segment I
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Karnataka Antibiotics and Pharmaceuticals
PLI min. annual capacity
Not applicable
End-use
Antibiotic intermediate
Last updated
24 Sept 2026
Clavulanic Acid
Segment
Segment I
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Kinvan
PLI min. annual capacity
Not applicable
End-use
Beta-lactamase inhibitor
Last updated
24 Sept 2026
Erythromycin Thiocyanate
Segment
Segment I
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
800 MT
End-use
Antibiotic
Last updated
9 Oct 2026
Penicillin G
Segment
Segment I
HS code(s)
29411010
China share
Not known
PLI critical list
Yes
Approved project
Aurobindo Pharma (via Lyfius Pharma)
PLI min. annual capacity
Not applicable
End-use
Antibiotic
Last updated
24 Sept 2026
Betamethasone
Segment
Segment II
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Natural Biogenex
PLI min. annual capacity
Not applicable
End-use
Corticosteroid
Last updated
24 Sept 2026
Clindamycin Base
Segment
Segment II
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
60 MT
End-use
Antibiotic
Last updated
9 Oct 2026
Dexamethasone
Segment
Segment II
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Natural Biogenex
PLI min. annual capacity
Not applicable
End-use
Corticosteroid
Last updated
24 Sept 2026
Gentamycin
Segment
Segment II
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
40 MT
End-use
Antibiotic
Last updated
9 Oct 2026
Neomycin
Segment
Segment II
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
80 MT
End-use
Antibiotic
Last updated
9 Oct 2026
Prednisolone
Segment
Segment II
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Natural Biogenex
PLI min. annual capacity
Not applicable
End-use
Corticosteroid
Last updated
24 Sept 2026
Rifampicin
Segment
Segment II
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Macleods
PLI min. annual capacity
Not applicable
End-use
Antibiotic
Last updated
24 Sept 2026
Streptomycin
Segment
Segment II
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
50 MT
End-use
Antibiotic
Last updated
9 Oct 2026
Tetracycline
Segment
Segment II
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
200 MT
End-use
Antibiotic
Last updated
9 Oct 2026
Vitamin B1
Segment
Segment II
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Sudarshan Pharma Industries
PLI min. annual capacity
Not applicable
End-use
Vitamin
Last updated
24 Sept 2026
1,1 Cyclohexane Diacetic Acid
Segment
Segment III
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Emmennar Pharma
PLI min. annual capacity
1,500 MT
End-use
Chemical intermediate
Last updated
9 Oct 2026
2-Methyl-5-Nitro-Imidazole
Segment
Segment III
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
800 MT
End-use
Chemical intermediate
Last updated
9 Oct 2026
Dicyandiamide
Segment
Segment III
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
8,000 MT
End-use
Chemical intermediate
Last updated
9 Oct 2026
Para amino phenol
Segment
Segment III
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Meghmani
PLI min. annual capacity
Not applicable
End-use
Chemical intermediate
Last updated
24 Sept 2026
Acyclovir
Segment
Segment IV
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
Not applicable
End-use
Antiviral
Last updated
24 Sept 2026
Artesunate
Segment
Segment IV
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
Not applicable
End-use
Antimalarial
Last updated
24 Sept 2026
Aspirin
Segment
Segment IV
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
Not applicable
End-use
Analgesic / NSAID
Last updated
24 Sept 2026
Atorvastatin
Segment
Segment IV
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
Not applicable
End-use
Cardiovascular
Last updated
24 Sept 2026
Carbamazepine
Segment
Segment IV
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
Not applicable
End-use
Anticonvulsant
Last updated
24 Sept 2026
Carbidopa
Segment
Segment IV
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
Not applicable
End-use
Antiparkinson's
Last updated
24 Sept 2026
Ciprofloxacin
Segment
Segment IV
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
150 MT
End-use
Antibiotic
Last updated
9 Oct 2026
Diclofenac Sodium
Segment
Segment IV
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
175 MT
End-use
Analgesic / NSAID
Last updated
9 Oct 2026
Levetiracetam
Segment
Segment IV
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
Not applicable
End-use
Anticonvulsant
Last updated
24 Sept 2026
Levodopa
Segment
Segment IV
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
Not applicable
End-use
Antiparkinson's
Last updated
24 Sept 2026
Levofloxacin
Segment
Segment IV
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
Not applicable
End-use
Antibiotic
Last updated
24 Sept 2026
Lopinavir
Segment
Segment IV
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
Not applicable
End-use
Antiviral
Last updated
24 Sept 2026
Losartan
Segment
Segment IV
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
Not applicable
End-use
Antihypertensive
Last updated
24 Sept 2026
Meropenem
Segment
Segment IV
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
4 MT
End-use
Antibiotic
Last updated
9 Oct 2026
Norfloxacin
Segment
Segment IV
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
Not applicable
End-use
Antibiotic
Last updated
24 Sept 2026
Ofloxacin
Segment
Segment IV
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
Not applicable
End-use
Antibiotic
Last updated
24 Sept 2026
Olmesartan
Segment
Segment IV
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
Not applicable
End-use
Antihypertensive
Last updated
24 Sept 2026
Oxcarbazepine
Segment
Segment IV
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
Not applicable
End-use
Anticonvulsant
Last updated
24 Sept 2026
Ritonavir
Segment
Segment IV
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
5 MT
End-use
Antiviral
Last updated
9 Oct 2026
Sulfadiazine
Segment
Segment IV
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
Not applicable
End-use
Antibiotic
Last updated
24 Sept 2026
Telmisartan
Segment
Segment IV
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
Not applicable
End-use
Antihypertensive
Last updated
24 Sept 2026
Valsartan
Segment
Segment IV
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
Not applicable
End-use
Antihypertensive
Last updated
24 Sept 2026
Vitamin B6
Segment
Segment IV
HS code(s)
—
China share
Not known
PLI critical list
Yes
Approved project
Not known
PLI min. annual capacity
Not applicable
End-use
Vitamin
Last updated
24 Sept 2026
6-APA
Segment
Not on PLI 41
HS code(s)
29411050
China share
Not known
PLI critical list
No
Approved project
No
PLI min. annual capacity
Not applicable
End-use
Antibiotic intermediate
Last updated
24 Sept 2026
Amoxicillin Trihydrate
Segment
Not on PLI 41
HS code(s)
29411030
China share
Not known
PLI critical list
No
Approved project
No
PLI min. annual capacity
Not applicable
End-use
Antibiotic
Last updated
24 Sept 2026